Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma

doi:10.3748/wjg.v25.i19.2365

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6386)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

388

WORD

184

HTML

3833

Figures (1-2)

171

Tables (1-3)

160

Sum=4736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

621

Download

1029

Sum=1650

May 21, 2019 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. May 21, 2019; 25(19): 2365-2372
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2365

Table 3 The performance characteristics of the rate of change of time-intensity curve parameters for the prediction of responders

	Slope (95%CI)	TTP (95%CI)	AUC (95%CI)
AUROC	0.818 (0.602-0.944)	0.869 (0.728-0.975)	0.939 (0.812-0995)
Cut-off value (%)	-11.765	+9.495	-25.714
Sensitivity	0.889 (0.540-0.978)	0.889 (0.540-0.978)	0.896 (0.616-0.989)
Specificity	0.545 (0.304-0.786)	0.818 (0.510-0.917)	0.909 (0.648-0.995)
PPV	0.615 (0.583-0.793)	0.800 (0.611-0.907)	0.833 (0.727-0.918)
NPV	0.857 (0.731-0.922)	0.878 (0.741-0.962)	0.900 (0.747-0.992)

TIC: Time-intensity curve; CI: Confidence interval; TTP: Time to peak; AUC: Area under the curve; AUROC: Area under receiver operating curve; PPV: Positive predictive value; NPV: Negative predictive value.

Citation: Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2019; 25(19): 2365-2372
URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2365.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i19.2365